154 related articles for article (PubMed ID: 32081023)
1. The two-week rule colorectal cancer pathway: an update on recent practice, the unsustainable burden on diagnostics and the role of faecal immunochemical testing.
Maclean W; Singh R; Mackenzie P; White D; Benton S; Stebbing J; Rockall T; Jourdan I
Ann R Coll Surg Engl; 2020 Apr; 102(4):308-311. PubMed ID: 32081023
[TBL] [Abstract][Full Text] [Related]
2. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.
Westwood M; Corro Ramos I; Lang S; Luyendijk M; Zaim R; Stirk L; Al M; Armstrong N; Kleijnen J
Health Technol Assess; 2017 May; 21(33):1-234. PubMed ID: 28643629
[TBL] [Abstract][Full Text] [Related]
3. Faecal immunochemical testing and blood tests for prioritization of urgent colorectal cancer referrals in symptomatic patients: a 2-year evaluation.
Bailey JA; Weller J; Chapman CJ; Ford A; Hardy K; Oliver S; Morling JR; Simpson JA; Humes DJ; Banerjea A
BJS Open; 2021 Mar; 5(2):. PubMed ID: 33693553
[TBL] [Abstract][Full Text] [Related]
4. Attitudes towards faecal immunochemical testing in patients at increased risk of colorectal cancer: an online survey of GPs in England.
von Wagner C; Stoffel S; Freeman M; Laszlo H; Nicholson BD; Sheringham J; Szinay D; Hirst Y
Br J Gen Pract; 2018 Nov; 68(676):e757-e764. PubMed ID: 30297435
[TBL] [Abstract][Full Text] [Related]
5. Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study.
Loveday C; Sud A; Jones ME; Broggio J; Scott S; Gronthound F; Torr B; Garrett A; Nicol DL; Jhanji S; Boyce SA; Williams M; Barry C; Riboli E; Kipps E; McFerran E; Muller DC; Lyratzopoulos G; Lawler M; Abulafi M; Houlston RS; Turnbull C
Gut; 2021 Jun; 70(6):1053-1060. PubMed ID: 32855306
[TBL] [Abstract][Full Text] [Related]
6. High-risk symptoms and quantitative faecal immunochemical test accuracy: Systematic review and meta-analysis.
Pin Vieito N; Zarraquiños S; Cubiella J
World J Gastroenterol; 2019 May; 25(19):2383-2401. PubMed ID: 31148909
[TBL] [Abstract][Full Text] [Related]
7. An urgent referral strategy for symptomatic patients with suspected colorectal cancer based on a quantitative immunochemical faecal occult blood test.
Rodríguez-Alonso L; Rodríguez-Moranta F; Ruiz-Cerulla A; Lobatón T; Arajol C; Binefa G; Moreno V; Guardiola J
Dig Liver Dis; 2015 Sep; 47(9):797-804. PubMed ID: 26055489
[TBL] [Abstract][Full Text] [Related]
8. Straight-to-test for the two-week-wait colorectal cancer pathway under the updated NICE guidelines reduces time to cancer diagnosis and treatment.
Christopher J; Flint TR; Ahmed H; Dhir N; Li R; Macfarland K; Ng D; Ng J; O'Neill C; Te Water Naudé A; Sloan K; Hall NR; Powar MP
Ann R Coll Surg Engl; 2019 May; 101(5):333-339. PubMed ID: 31042431
[TBL] [Abstract][Full Text] [Related]
9. Assessment of a rapid referral pathway for suspected colorectal cancer in Madrid.
Valentín-López B; Ferrándiz-Santos J; Blasco-Amaro JA; Morillas-Sáinz JD; Ruiz-López P
Fam Pract; 2012 Apr; 29(2):182-8. PubMed ID: 21976660
[TBL] [Abstract][Full Text] [Related]
10. Adoption of faecal immunochemical testing for 2-week-wait colorectal patients during the COVID-19 pandemic: an observational cohort study reporting a new service at a regional centre.
Maclean W; Limb C; Mackenzie P; Whyte MB; Benton SC; Rockall T; Jourdan I
Colorectal Dis; 2021 Jul; 23(7):1622-1629. PubMed ID: 33068489
[TBL] [Abstract][Full Text] [Related]
11. The use of the faecal immunochemical test during the COVID-19 pandemic to triage urgent colorectal cancer referrals.
Kamel F; Zulfiqar S; Penfold W; Weatherell S; Madani R; Nisar P; Bearn P
Colorectal Dis; 2022 Jun; 24(6):727-736. PubMed ID: 35297169
[TBL] [Abstract][Full Text] [Related]
12. Impact of the United kingdom national bowel cancer awareness campaign on colorectal services.
Pande R; Leung E; McCullough P; Smith S; Harmston C
Dis Colon Rectum; 2014 Jan; 57(1):70-5. PubMed ID: 24316948
[TBL] [Abstract][Full Text] [Related]
13. Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial.
Forsberg A; Westerberg M; Metcalfe C; Steele R; Blom J; Engstrand L; Fritzell K; Hellström M; Levin LÅ; Löwbeer C; Pischel A; Strömberg U; Törnberg S; Wengström Y; Ekbom A; Holmberg L; Hultcrantz R;
Lancet Gastroenterol Hepatol; 2022 Jun; 7(6):513-521. PubMed ID: 35298893
[TBL] [Abstract][Full Text] [Related]
14. The increasing burden of the 2-week wait colorectal cancer pathway in a single centre: the impact of faecal immunochemical tests.
Farkas N; O'Brien JW; Palyvos L; Maclean W; Benton S; Rockall T; Jourdan I
Ann R Coll Surg Engl; 2024 Apr; 106(4):338-343. PubMed ID: 36688865
[TBL] [Abstract][Full Text] [Related]
15. The 2-week wait service: a UK tertiary colorectal centre's experience in the early identification of colorectal cancer.
Patel RK; Sayers AE; Seedat S; Altayeb T; Hunter IA
Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1408-14. PubMed ID: 25244412
[TBL] [Abstract][Full Text] [Related]
16. Developing a prioritization model for endoscopy and colorectal cancer 2-week wait referrals during the COVID-19 pandemic-is faecal immunochemical testing the answer?
Habib Bedwani N; English W; Coda S; Akinlade F; Elzayat I; Seward EW; Hayee B; Hanson M; Banerjee S
Br J Surg; 2021 Jan; 108(1):e18-e19. PubMed ID: 33640923
[TBL] [Abstract][Full Text] [Related]
17. Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis.
Medina-Lara A; Grigore B; Lewis R; Peters J; Price S; Landa P; Robinson S; Neal R; Hamilton W; Spencer AE
Health Technol Assess; 2020 Nov; 24(66):1-332. PubMed ID: 33252328
[TBL] [Abstract][Full Text] [Related]
18. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline.
Helsingen LM; Vandvik PO; Jodal HC; Agoritsas T; Lytvyn L; Anderson JC; Auer R; Murphy SB; Almadi MA; Corley DA; Quinlan C; Fuchs JM; McKinnon A; Qaseem A; Heen AF; Siemieniuk RAC; Kalager M; Usher-Smith JA; Lansdorp-Vogelaar I; Bretthauer M; Guyatt G
BMJ; 2019 Oct; 367():l5515. PubMed ID: 31578196
[TBL] [Abstract][Full Text] [Related]
19. Incorporating faecal haemoglobin measurement using the faecal immunochemical test (FIT) in the referral, triage and prioritisation pathway for patients with colorectal symptoms.
Falvey J; Frampton CMA; Gearry RB; Hudson B; Whiteley L
N Z Med J; 2023 Jul; 136(1578):55-76. PubMed ID: 37414077
[TBL] [Abstract][Full Text] [Related]
20. Introduction of an integrated primary care faecal immunochemical test referral pathway for patients with suspected colorectal cancer symptoms.
Georgiou Delisle T; D'Souza N; Tan J; Najdawi A; Chen M; Ward H; Abulafi M
Colorectal Dis; 2022 Dec; 24(12):1526-1534. PubMed ID: 35934985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
